Cargando…
Direct pharmacological assessment of clinically acquired models as a strategy to overcome resistance to tyrosine kinase inhibitors
We have performed a study using cell lines established from biopsies of clinically resistant non-small cell lung cancers with the aim of discovering therapeutic strategies to overcome acquired resistance. Our results indicate that pharmacological assessment of tumor material might efficiently comple...
Autor principal: | Benes, Cyril H |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4905366/ https://www.ncbi.nlm.nih.gov/pubmed/27308520 http://dx.doi.org/10.1080/23723556.2014.999504 |
Ejemplares similares
-
New strategies for melanoma immunotherapy: How to overcome immunosuppression in the tumor microenvironment
por: Umansky, Viktor
Publicado: (2012) -
Overcoming resistance to immunotherapy by teaching old drugs new tricks
por: Perry, John M., et al.
Publicado: (2020) -
High-affinity peptide-based anticancer vaccination to overcome resistance to immunostimulatory antibodies
por: Binder, David C, et al.
Publicado: (2013) -
The acidity of the tumor microenvironment is a mechanism of immune escape that can be overcome by proton pump inhibitors
por: Bellone, Matteo, et al.
Publicado: (2013) -
A new “angle” on kinase inhibitor design: Prioritizing amphosteric activity above kinase inhibition
por: Meyerowitz, Justin G, et al.
Publicado: (2015)